Deficiency of apoptosis-stimulating protein two of p53 promotes liver regeneration in mice by activating mammalian target of rapamycin.

作者: Hongbo Shi , Yizhi Zhang , Jing Ji , Ping Xu , Honglin Shi

DOI: 10.1038/S41598-018-36208-3

关键词:

摘要: Although liver regeneration has been intensively studied in various ways, the mechanisms underlying remain elusive. Apoptosis-stimulating protein two of p53 (ASPP2) was discovered as a binding partner and plays an important role regulating cell apoptosis growth. However, ASPP2 hepatocyte proliferation not reported. The expression profile measured mouse model with 70% partial hepatectomy (PHX). Liver were detected wild-type (ASPP2+/+) haploinsufficient (ASPP2+/−) mice PHX. mammalian target rapamycin (mTOR) autophagy pathways analyzed ASPP2+/+ ASPP2+/− After or 3-methyladenine (3-MA) treatment, shown to be upregulated at early stage downregulated late stage. Compared mice, enhanced In addition, compared mTORC1 pathway significantly autophagic ASPP2+/−mice Inhibition suppressed contrast, disruption further deficiency can promote through activating pathway, which regulates downstream molecules, such those related p70S6K post-PHX.

参考文章(31)
Lingling Zhang, Leiming Liu, Zhiyong He, Guangbing Li, Junping Liu, Zhangfa Song, Hongchuan Jin, Karl Lenhard Rudolph, Huayu Yang, Yilei Mao, Lianfeng Zhang, Hongbing Zhang, Zhicheng Xiao, Zhenyu Ju, Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin Hepatology. ,vol. 61, pp. 2030- 2041 ,(2015) , 10.1002/HEP.27755
Hong-Min Ni, Jessica A Williams, Hartmut Jaeschke, Wen-Xing Ding, Zonated induction of autophagy and mitochondrial spheroids limits acetaminophen-induced necrosis in the liver Redox biology. ,vol. 1, pp. 427- 432 ,(2013) , 10.1016/J.REDOX.2013.08.005
K Liu, Y Shi, X Guo, S Wang, Y Ouyang, M Hao, D Liu, L Qiao, N Li, J Zheng, D Chen, CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2 Cell Death and Disease. ,vol. 5, ,(2014) , 10.1038/CDDIS.2014.276
Ganna Panasyuk, Cecilia Patitucci, Catherine Espeillac, Mario Pende, The role of the mTOR pathway during liver regeneration and tumorigenesis Annales d'Endocrinologie. ,vol. 74, pp. 121- 122 ,(2013) , 10.1016/J.ANDO.2013.03.003
Fang Xie, Lin Jia, Minghua Lin, Ying Shi, Jiming Yin, Yin Liu, Dexi Chen, Qinghua Meng, ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease. Journal of Cellular and Molecular Medicine. ,vol. 19, pp. 155- 164 ,(2015) , 10.1111/JCMM.12364
Kerstin M. Kampa, Michael Bonin, Charles D. Lopez, New insights into the expanding complexity of the tumor suppressor ASPP2. Cell Cycle. ,vol. 8, pp. 2871- 2876 ,(2009) , 10.4161/CC.8.18.9474
Ying Shi, Yue Han, Fang Xie, Anna Wang, Xiaokun Feng, Ning Li, Hongliang Guo, Dexi Chen, ASPP2 enhances Oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy Journal of Cellular and Molecular Medicine. ,vol. 19, pp. 535- 543 ,(2015) , 10.1111/JCMM.12435
Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi, None, Clinical implications of advances in liver regeneration Clinical and molecular hepatology. ,vol. 21, pp. 7- 13 ,(2015) , 10.3350/CMH.2015.21.1.7
Suomi MG Fouraschen, Petra E de Ruiter, Jaap Kwekkeboom, Ron WF de Bruin, Geert Kazemier, Herold J Metselaar, Hugo W Tilanus, Luc JW van der Laan, Jeroen de Jonge, mTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment. World journal of transplantation. ,vol. 3, pp. 36- 47 ,(2013) , 10.5500/WJT.V3.I3.36